Target intelligence / Profile preview

Reactive intermediate deaminase A (RidA)

Target
RidA
Molecular classification
Enzyme (specifically, enamine/imine deaminase), Member of the Rid (YjgF/YER057c/UK114) protein superfamily[1][4], Other (sometimes exhibits molecular chaperone and ribonuclease activity)[2][5]
01

Overview

Reactive intermediate deaminase A (RidA) is an evolutionarily conserved enzyme found in bacteria, archaea, and eukaryotes. RidA belongs to the Rid (YjgF/YER057c/UK114) superfamily and catalyzes the hydrolysis (deamination) of reactive enamine and imine intermediates, such as 2-aminoacrylate, generated by pyridoxal 5'-phosphate (PLP)-dependent enzymatic reactions. These intermediates, if not rapidly detoxified, can inactivate other essential PLP-dependent enzymes, leading to metabolic damage. By converting unstable and potentially harmful intermediates to stable keto acids, RidA safeguards cellular metabolism and supports amino acid biosynthesis. In addition to its primary enzymatic role, RidA has been reported to display molecular chaperone activity during oxidative stress and may possess ribonuclease or translational inhibition functions in some homologs, especially in higher eukaryotes. RidA dysfunction or deficiency has pleiotropic cellular impacts, and variants have been linked to altered amino acid biosynthesis, stress responses, and possibly cancer progression[1][2][3][4][5].

Other names
2-iminobutanoate/2-iminopropanoate deaminaseHRSP12hp14.5p14.5UK114P14.5PSP14.5 kDa translational inhibitor proteinHeat-responsive protein 12Translation inhibitor L-PSP ribonucleaseUK114 antigen homologperchloric acid-soluble proteinreactive intermediate imine deaminase A homologribonuclease UK114translational inhibitor p14.5
02

Biological functions

Detoxification of reactive intermediates (enamine/imine hydrolysis)[1][2][3][4]Protection of pyridoxal 5'-phosphate (PLP)-dependent enzymes from metabolic damage[2][3][4]Protein chaperone activity under oxidative stress[5]Possible translation inhibition and ribonuclease activity (less well-established, mostly in eukaryotic homologs)[2][5]
03

Disease associations

Cancer (implicated in carcinogenesis and cell proliferation)[1]Other (cellular stress response and general cellular metabolism)[1][2][5]

Beyond the preview

Go deeper on Reactive intermediate deaminase A (RidA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive intermediate deaminase A (RidA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call